Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Total 13F shares
-
2,428,981
-
Share change
-
+234,263
-
Total reported value
-
$586,523,151
-
Price per share
-
$240.87
-
Number of holders
-
141
-
Value change
-
+$54,739,344
-
Number of buys
-
50
-
Number of sells
-
74
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q4 2025
As of 31 Dec 2025,
RESMED INC - Common Stock (RMD) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,428,981 shares.
The largest 10 holders included
NORDEA INVESTMENT MANAGEMENT AB, Aberdeen Group plc, CONFLUENCE INVESTMENT MANAGEMENT LLC, Assenagon Asset Management S.A., Addenda Capital Inc., MassMutual Private Wealth & Trust, FSB, NISA INVESTMENT ADVISORS, LLC, Mn Services Vermogensbeheer B.V., NorthCrest Asset Manangement, LLC, and SG Americas Securities, LLC.
This page lists
141
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.